Conference Proceedings
Long-Term Follow-up of the ALLG CML8 Twister Study of Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia (CML)
David M Ross, Ilaria S Pagani, Naranie Shanmuganathan, John F Seymour, Anthony K Mills, Robin J Filshie, Christopher K Arthur, Dang Phuong, Verity A Saunders, Jody Braley, David T Yeung, Deborah L White, Andrew P Grigg, Anthony P Schwarer, Susan Branford, Timothy P Hughes
BLOOD | AMER SOC HEMATOLOGY | Published : 2017
Grants
Funding Acknowledgements
Shanmuganathan: Novartis: Honoraria, Other: Travel Support; Bristol-Myers Squibb: Honoraria, Other: Travel Support. Mills: Novartis: Honoraria; Bristol-Myers Squibb: Honoraria; Specialised Therapeutics: Honoraria. Yeung: Novartis: Honoraria, Research Funding; Bristol-Myers Squibb: Honoraria, Research Funding; Ariad: Honoraria, Research Funding. White: Novartis: Consultancy, Honoraria, Research Funding; BMS: Consultancy, Honoraria, Research Funding; Ariad: Consultancy, Honoraria, Research Funding. Grigg: Merck Sharpe Dohme: Membership on an entity's Board of Directors or advisory committees; Roche: Membership on an entity's Board of Directors or advisory committees, Other: Travel expenses; Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees; Amgen: Membership on an entity's Board of Directors or advisory committees, Other: Travel expenses. Schwarer: Specialised Therapeutics: Honoraria; Amgen: Honoraria; Roche: Honoraria; Celgene: Honoraria; Bristol-Myers Squibb: Honoraria; Novartis: Honoraria. Branford: Qiagen: Honoraria, Membership on an entity's Board of Directors or advisory committees; Bristol-Myers Squibb: Honoraria; Ariad: Honoraria, Research Funding; Otsuka: Honoraria, Research Funding; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau. Hughes: Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Bristol-Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Ariad: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding.